Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
The Rutherford Cancer Centres and Elekta are bringing the next generation of personalised adaptive radiotherapy technology to oncology centres across the UK, with the new MR-linac Elekta Unity now available at the Rutherford Cancer Centre North West in Liverpool.
Consultant Clinical Oncologist
Dr Enrico Clarke is a Consultant Clinical Oncologist based at the Rutherford Cancer Centre in Thames Valley, specialising in the treatment of patients with brain tumours.
He was born and educated in Italy and trained in Medicine at University Sapienza in Rome with fellowships at the Royal Marsden Hospital, University College Hospital, and observership at M.D. Anderson Cancer Centre in Texas.
Dr Clarke has worked as a consultant in neuro-oncology since February 2019 and has worked as a clinical fellow at the Clatterbridge Cancer Centre and at The Royal Marsden Hospital.
He provides radiotherapy and systemic treatment for brain, skull-base, pituitary and spinal tumours and participates in the ongoing development and delivery of proton beam therapy.
Dr Clarke loves music, art and travelling. He enjoys physical activity including cycling and hiking especially on the South Coast of England.
Neuro-Oncology, Skull-base, Pituitary, Spinal tumours.
Research Interests:
Dr Clarke has an interest in technical developments in radiotherapy, including advanced treatment techniques such as stereotactic radiotherapy, intensity-modulated radiotherapy, image-guided radiotherapy and proton beam therapy with a particular focus on the treatment of benign and malignant brain tumours.
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or
© Copyright Rutherford Health Plc 2017 - 2022
All rights Reserved